A. Lucas

发表

A Sensitive High Performance Liquid Chromatography (HPLC) Assay for the Quantification of Doxorubicin Bound to DNA

A. Lucas, 2014 .

Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains.

Andrew T. Lucas, T. Wiltshire, W. Zamboni, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents

W. Zamboni, Andrew J. Madden, A. Lucas, 2015, Expert opinion on drug metabolism & toxicology.

Translation to the Clinic: Preclinical and Clinical Pharmacology Studies of Nanoparticles – The Translational Challenge

W. Zamboni, Andrew J. Madden, Leah Osae, 2016 .

Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2.

Andrew T. Lucas, S. Lai, W. Zamboni, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients

P. Gehrig, W. Zamboni, J. Bensen, 2018, Cancer Chemotherapy and Pharmacology.

Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients

Andrew T. Lucas, J. Piscitelli, W. Zamboni, 2019, Antibodies.

Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective

W. Zamboni, Allison N. Schorzman, A. Lucas, 2021, Antibodies.

Factors Affecting the Pharmacology of Antibody–Drug Conjugates

J. Piscitelli, W. Zamboni, Allison N. Schorzman, 2018, Antibodies.

Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations.

William C Zamboni, Janos Szebeni, Serguei V Kozlov, 2018, Advanced drug delivery reviews.

Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.

W. Zamboni, Allison N. Schorzman, J. Kagel, 2018, Methods in molecular biology.

Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia

D. Triulzi, A. Ilich, N. Key, 2022, Blood advances.

Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models.

A. Deal, W. Zamboni, G. Song, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems

Andrew T. Lucas, W. Zamboni, Jisun Ban, 2021, Pharmaceutics.

Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

W. Zamboni, Allison N. Schorzman, Lauren S. L. Price, 2017, Nanomedicine.

Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.

Andrew T. Lucas, W. Zamboni, Andrew J. Madden, 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs.

A. Gabizon, A. Kabanov, P. Kulanthaivel, 2017, International journal of pharmaceutics.

A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues.

W. Zamboni, Charlene M. Santos, Sara K O'Neal, 2016, Journal of pharmaceutical and biomedical analysis.

Semantic Pleonasm Detection

Rebecca Hwa, Omid Kashefi, Andrew T. Lucas, 2018, NAACL.

Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?

J. Meyerhardt, S. Bhatia, E. Acosta, 2021 .